These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28493543)

  • 1. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration.
    Partin MR; Powell AA; Bangerter A; Halek K; Burgess JF; Fisher DA; Nelson DB
    J Gen Intern Med; 2012 Dec; 27(12):1618-25. PubMed ID: 22810358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.
    Partin MR; Burgess DJ; Burgess JF; Gravely A; Haggstrom D; Lillie SE; Nugent S; Powell AA; Shaukat A; Walter LC; Nelson DB
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):422-34. PubMed ID: 25471345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
    Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
    Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of colorectal cancer screening in veterans based on the location of primary care clinic.
    Malhotra A; Vaughan-Sarrazin M; Charlton ME; Rosenthal GE
    J Prim Care Community Health; 2014 Jan; 5(1):24-9. PubMed ID: 24327586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening mode preferences among US veterans.
    Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
    Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals.
    Partin MR; Powell AA; Nugent S; Ordin DL
    J Healthc Qual; 2013; 35(3):41-8. PubMed ID: 22192595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the management of positive fecal occult blood tests.
    Rao SK; Schilling TF; Sequist TD
    J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.
    McCarthy AM; Kim JJ; Beaber EF; Zheng Y; Burnett-Hartman A; Chubak J; Ghai NR; McLerran D; Breen N; Conant EF; Geller BM; Green BB; Klabunde CN; Inrig S; Skinner CS; Quinn VP; Haas JS; Schnall M; Rutter CM; Barlow WE; Corley DA; Armstrong K; Doubeni CA;
    Am J Prev Med; 2016 Oct; 51(4):507-12. PubMed ID: 27132628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with colon cancer screening: the role of patient factors and physician counseling.
    Wee CC; McCarthy EP; Phillips RS
    Prev Med; 2005 Jul; 41(1):23-9. PubMed ID: 15916989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.